Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene
Although duloxetine is the only drug recommended by the American Society of Clinical Oncology that can be used for the management of chemotherapy induced peripheral neuropathy (Loprinzi et al., 2020), this recommendation was not followed in clinical practice
Typical maintenance: 40-60% of active weight loss dose Gradual reduction over 4-6 weeks per step Close weight monitoring during reduction Return to higher dose if regain begins Individual response varies significantly Indefinite Treatment Perspective Obesity medicine increasingly recognizes pharmaceutical weight loss as long-term therapy rather than temporary intervention
In addition to the direct removal of toxic ions from the environment, bacteria and their metabolites can reduce the harmful effects of plant exposure to heavy metals
Younossi 1,2,3 , Reem Al Shabeeb 4 , Katherine Elizabeth Eberly 4 , Dipam Shah 4 , Veronica Nguyen 1 , Janus Ong 5 , Saleh A Alqahtani 6 , Linda Henry 1,4,7 and Maria Stepanova 7 , (1)Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, (2)Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, VA, (3)Inova Medicine, Inova Health System, Falls Church, VA, (4)Inova Health Systems Medicine Service Line, Falls Church, VA, (5)College of Medicine, University of the Philippines, Manila, Philippines, (6)Johns Hopkins University School of Medicine, (7)Center for Outcomes Research in Liver Diseases, Washington, DC Background: High prevalence of obesity in the U.S
[3] No equivalent human pharmacokinetic dataset appears in the indexed literature
